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Logistic regressionMagnetic resonance imaging (MRI) can be used to detect lesions in the brains of multiple sclerosis (MS)
patients and is essential for diagnosing the disease and monitoring its progression. In practice, lesion load
is often quantiﬁed by either manual or semi-automated segmentation of MRI, which is time-consuming, cost-
ly, and associated with large inter- and intra-observer variability. We propose OASIS is Automated Statistical
Inference for Segmentation (OASIS), an automated statistical method for segmenting MS lesions in MRI stud-
ies. We use logistic regression models incorporating multiple MRI modalities to estimate voxel-level proba-
bilities of lesion presence. Intensity-normalized T1-weighted, T2-weighted, ﬂuid-attenuated inversion
recovery and proton density volumes from 131 MRI studies (98 MS subjects, 33 healthy subjects) with man-
ual lesion segmentations were used to train and validate our model. Within this set, OASIS detected lesions
with a partial area under the receiver operating characteristic curve for clinically relevant false positive
rates of 1% and below of 0.59% (95% CI; [0.50%, 0.67%]) at the voxel level. An experienced MS neuroradiologist
compared these segmentations to those produced by LesionTOADS, an image segmentation software that
provides segmentation of both lesions and normal brain structures. For lesions, OASIS out-performed
LesionTOADS in 74% (95% CI: [65%, 82%]) of cases for the 98 MS subjects.
To further validate the method, we applied OASIS to 169 MRI studies acquired at a separate center. The neu-
roradiologist again compared the OASIS segmentations to those from LesionTOADS. For lesions, OASIS ranked
higher than LesionTOADS in 77% (95% CI: [71%, 83%]) of cases. For a randomly selected subset of 50 of these
studies, one additional radiologist and one neurologist also scored the images. Within this set, the neurora-
diologist ranked OASIS higher than LesionTOADS in 76% (95% CI: [64%, 88%]) of cases, the neurologist 66%
(95% CI: [52%, 78%]) and the radiologist 52% (95% CI: [38%, 66%]).
OASIS obtains the estimated probability for each voxel to be part of a lesion by weighting each imaging mo-
dality with coefﬁcient weights. These coefﬁcients are explicit, obtained using standard model ﬁtting tech-
niques, and can be reused in other imaging studies. This fully automated method allows sensitive and
speciﬁc detection of lesion presence and may be rapidly applied to large collections of images.
© 2013 The Authors. Published by Elsevier Inc. All rights reserved.erms of the Creative Commons
permits non-commercial use,
the original author and source
cs, 615 N Wolfe Street, E3518,
y).
blished by Elsevier Inc. All rights re1. Introduction
Multiple sclerosis (MS) is an inﬂammatory disease of the brain and
spinal cord characterized by demyelinating lesions that are most easily
identiﬁed, at least on magnetic resonance imaging (MRI) studies, in the
white matter of the brain (Sahraian and Radue, 2007). Quantitative
analyses ofMRI, such as the number and volume of lesions, are essential
for diagnosing the disease and monitoring its progression (Rovira and
León, 2008; Rovira et al., 2009). MRI measures are also a commonserved.
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trials (Sormani et al., 2009). In these trials, either manual or semi-
automated segmentations are used to compute the total number of le-
sions and the total lesion volume (Lladó et al., 2011). Manual delinea-
tion is challenging as three-dimensional information from several MRI
modalities must be integrated (Lladó et al., 2011). Manual assessment
of MRI is also prone to large inter- and intra-observer variability
(Simon et al., 2006). While semi-automated methods have been found
to decrease inter- and intra-rater variability, they still require manual
reader input and are time consuming (García-Lorenzo et al., 2013).
Therefore a sensitive and speciﬁc automated method to detect lesions
in the brain is essential for the analysis of studies with a high numbers
of MS patients.
Lladó et al. (2011) provides a comprehensive review of currently
available automated cross-sectional MS lesion segmentation methods,
or methods used to identify lesions from a single MRI study. We divide
these methods into four categories: supervised classiﬁer with an atlas,
supervised classiﬁer with no atlas, unsupervised classiﬁer with an
atlas, and unsupervised classiﬁer with no atlas. We focus on supervised
methods without atlases, as the method we propose is in this category.
Supervised methods without atlases train on manually segmented im-
ages annotated by experts and use image intensities of MRI to classify
lesions (Lladó et al., 2011). Supervised classiﬁcation algorithms are
applied to the volumes: artiﬁcial neural networks (Goldberg-Zimring
et al., 1998), spatial clustering (Alfano et al., 2000), k-nearest neighbors
(Anbeek et al., 2004, 2005, 2008), Parzen window (Sajja et al., 2006),
Parzen window and morphological grayscale reconstruction (Datta
et al., 2006), Bayes (Scully et al., 2008), AdaBoost (Morra et al., 2008),
simulated annealing and Markov random ﬁelds (Subbanna et al.,
2009), and graph cuts (Lecoeur et al., 2009). All of the aforementioned
methods except Anbeek et al. (2008) use multi-modality MRI informa-
tion to classify lesions. The most widely-used feature across all seg-
mentation methods is voxel intensity, which derives strength from a
multi-modality approach (Lladó et al., 2011).
The method we propose uses a logistic regression model to assign
voxel-level probabilities of lesion presence in structural MRI of pa-
tients with MS. Logistic regression models have been used for seg-
mentation of brain tissues and pathology in MRI (Bullmore et al.,
1999; Dinh et al., 2012; Lee et al., 2005). For applications to MS, logis-
tic regression has been used for detection of gadolinium enhancing
lesions (Karimaghaloo et al., 2012), prediction of gadolinium enhanc-
ing lesions without administering contrast agents (Shinohara et al.,
2012), and for segmentation of new and enlarging MS lesions
(Sweeney et al., 2013). To our knowledge logistic regression has not
been used in cross-sectional segmentation of MS lesions in structural
MRI.
One difﬁculty in automated segmentation of MRI is due to variable
imaging acquisition parameters (Lladó et al., 2011). All of the seg-
mentation methods reviewed in Lladó et al. (2011) have tuning
parameters that are adjusted to a particular data set and may not gen-
eralize to a new data set with different acquisition parameters. These
parameters are not informed by the data and therefore must be tuned
empirically, often with little to no interpretability of the parameter.
Application to a new data set may require several iterations of seg-
mentations to adjust the tuning parameters to values that produce ac-
ceptable segmentations. A method in which the tuning parameters
are informed by the data and for which adjustments are intuitive
and simple would therefore be valuable.
A second difﬁculty in intensity-based segmentation is that MRI
data are acquired in arbitrary units; units can vary widely between
and within imaging centers. These variations are attributed to scan-
ner hardware, interactions between hardware and patients, and var-
iations in acquisition parameters (Simmons et al., 1994). Therefore,
proper intensity normalization is essential in developing a generaliz-
able segmentation method. Many of the segmentation methods
use intensity-normalized volumes (Lladó et al., 2011), but thesemethods do not demonstrate the generalizability of the normalization
procedure to changes in imaging acquisition parameters and imaging
centers. In García-Lorenzo et al. (2013) the authors performed a
PubMed and Google Scholar search for MS lesion segmentation pa-
pers. Of the 47 papers that met their search criteria, only 13 of these
papers used multicenter data for validation, and the largest database
used for validation consisted of 41 subjects. To show generalizability,
methods must be validated on multicenter data with many subjects.
A third difﬁculty is intensity inhomogeneity, the slow spatial in-
tensity variations of the same tissue within an MRI volume. Inhomo-
geneity can signiﬁcantly reduce the accuracy of image segmentation
(Hou, 2006), and therefore some form of spatial normalization is nec-
essary for accurate lesion segmentation. Most lesion segmentation
methods assume that these inhomogeneities have been corrected
during image preprocessing, but we have found strong spatial pat-
terns within tissue type even after the N3 inhomogeneity correction
algorithm (Sled et al., 1998) is applied.
To address these and related problems, we propose OASIS is Auto-
mated Statistical Inference for Segmentation (OASIS), a fully automat-
ed, generalizable, and novel statistical method for cross-sectional MS
lesion segmentation. Using intensity information from multiple mo-
dalities of MRI, a logistic regression model assigns voxel-level proba-
bilities of lesion presence. After training on manual segmentations,
the OASIS model produces interpretable results in the form of regres-
sion coefﬁcients that can be applied to imaging studies quickly and
easily. OASIS uses intensity-normalized brain MRI volumes, enabling
the model to generalize to changes in scanner and acquisition se-
quence. OASIS also adjusts for intensity inhomogeneities that prepro-
cessing bias ﬁeld correction procedures do not remove, using
smoothed volumes. This allows for more accurate segmentation of
brain areas that are highly distorted by inhomogeneities, such as
the cerebellum. One of the most practical properties of OASIS is that
the method is fully transparent, easy to explain and implement, and
simple to modify for new data sets.
To illustrate the generalizability of OASIS to changes in imaging
acquisition parameters, we evaluated the performance of the algo-
rithm on a total of 300MRI studies from two separate imaging centers
with varying acquisition parameters. This is a crucial criterion for
assessing the generalizability and utility of the method.
2. Materials and methods
In this section we introduce OASIS, a method inspired by Subtrac-
tion Based Inference for Modeling and Estimation (SuBLIME), an au-
tomated method for the longitudinal segmentation of incident and
enlarging MS lesions (Sweeney et al., 2013). Before the OASIS logistic
regression model is ﬁt, a brain tissue mask is created, all MRI volumes
are intensity normalized, and smoothed volumes are created to cap-
ture local spatial information and adjust for remaining ﬁeld inhomo-
geneities. The OASIS method involves two iterations of model ﬁtting:
the ﬁrst to perform an initial lesion segmentation and the second to
use this initial lesion segmentation to remove lesions, which can dis-
tort the smoothed volumes. After the ﬁnal model is ﬁt, the regression
coefﬁcients are applied to produce three dimensional maps of voxel-
level probabilities of lesion presence.
We evaluate the performance of OASIS on MRI volumes of the
brain acquired with various acquisition protocols. We use data sets
from two different imaging centers for validation, which we refer to
as Validation Set 1 and Validation Set 2. Validation Set 1 has manual
lesion segmentations. We trained the OASIS method on a subset of
the studies in this dataset, and tested on the remaining studies. An ex-
pert evaluated the segmentations from Validation Set 1. Validation
Set 2 is used to demonstrate generalizability to changes in image ac-
quisition parameters. We applied the coefﬁcients from the model
trained on Validation Set 1 to the studies in Validation Set 2, and ex-
perts evaluated the OASIS lesion segmentations.
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Validation Set 1 contains a total of 131 MRI studies from 131 sub-
jects. Of these studies, 98 are from patients with MS and 33 are
healthy volunteer scans. Of the 98 patients with MS, the median age
is 44 years (IQR: [33, 54]), 72 are female (26 male), and the median
EDSS is 3.5 (IQR:[2, 6]). The median age of the healthy volunteers is
34 (IQR: [28, 42]) and 19 are female (14 male).
Validation Set 2 contains a total of 169 MRI studies from 149 sub-
jects. Twenty subjects in Validation Set 2 have baseline and follow-up
scans. The mean time between baseline and follow-up for these 20
subjects is 132 days (IQR: [51, 182]). The subjects in the validation
set are a mixture of healthy volunteers and patients: 110 of the pa-
tients have MS, 38 have other neurological diseases, and one is a
healthy volunteer. The median age of the MS patients is 42 (IQR:
[33,50]); 54 are female (56 male); 68 have relapsing remitting MS,
31 have primary progressive MS, and 11 have secondary progressive
MS. The median age of the patients with other neurological diseases
is 41 years, (IQR: [35, 51]) and 8 are female (30 male). The healthy
volunteer is a 28 year old female.
2.2. Experimental methods
T1-weighted, T2-weighted, ﬂuid-attenuated inversion recovery
(FLAIR) and proton density (PD) volumes were acquired for all subjects
at each study, and all imaging protocols were approved by local institu-
tional review boards. For Validation Set 1, 3DT1-MPRAGE images
(repetition time (TR) = 10 ms; echo time (TE) = 6 ms; ﬂip angle
(FA) α = 8°; inversion time (TI) = 835 ms, resolution = 1.1 mm ×
1.1 mm × 1.1 mm), 2D T2-weighted pre-contrast FLAIR images
(TR = 11,000 ms; TE = 68 ms; TI = 2800 ms; in-plane resolution =
0.83 mm × 0.83 mm; slice thickness = 2.2 mm), T2-weighted and PD
images (TR = 4200 ms; TE = 12/80 ms; resolution = 0.83 mm ×
0.83 mm × 2.2 mm) were acquired on a 3 T MRI scanner (Philips
Medical Systems, Best, The Netherlands).
For Validation Set 2, the 3D T2-weighted post-contrast FLAIR was
acquired using a variable ﬂip angle sequence, the 2D PD and
T2-weighted volumes using a dual-echo fast-spin-echo sequence,
and the 3D T1-weighted volume using an inversion-prepared fast
spoiled gradient-echo sequence. These studies were acquired on a
single 3 T MRI scanner (Signa Excite HDxt; GE Healthcare, Milwaukee,
Wisconsin). Table 1 contains the ranges for the Validation Set 2 scan-
ning parameters.
2.3. Image preprocessing
Before building our statistical model for the lesion segmentation,
we preprocessed the images from Validation Set 1 and Validation
Set 2 using the tools provided in Medical Image Processing Analysis
and Visualization (MIPAV) (McAuliffe et al., 2001), TOADS-CRUISE
(http://www.nitrc.org/projects/toads-cruise/), and Java Image Sci-
ence Toolkit (JIST) (Lucas et al., 2010) software packages. We ﬁrst rig-
idly aligned the T1-weighted image of each subject into the Montreal
Neurological Institute (MNI) standard space (voxel resolution1mm3).
We then registered the FLAIR, PD, and T2-weighted images of each
subject to the aligned T1-weighted images. We also applied the N3 in-
homogeneity correction algorithm (Sled et al., 1998) to all images andTable 1
Ranges for Validation Set 2 scanning parameters.
FA (degrees) TR (ms) TE (ms) TI (ms)
FLAIR 90 (4800, 8802) (124.3, 151.4) (1481, 2200)
T2-weighted 90 5317 (116.2, 124.2) NA
PD 90 5317 (16.0, 23.7) NA
T1-weighted (6, 13) (8.7, 9.1) (3.2, 3.6) (450, 725)removed extracerebral voxels using SPECTRE, a skull-stripping proce-
dure (Carass et al., 2011).
2.4. Statistical modeling and spatial smoothing
We performed all statistical modeling in the R environment (ver-
sion 2.12.0, R Foundation for Statistical Computing, Vienna, Austria)
with the packages AnalyzeFMRI (Bordier et al., 2009), biglm
(Lumley, 2009), ff (Adler et al., 2011), and ROCR (Sing et al., 2009).
We used the FSL tool fslmaths (http://www.fmrib.ox.ac.uk/fsl) for
the three dimensional spatial smoothing of the volumes.
2.5. Brain tissue mask
The ﬁrst step in OASIS is to create a mask of the brain that excludes
cerebrospinal ﬂuid (CSF). CSF is excluded because it disrupts the cap-
ture of the inhomogeneity ﬁeld and distorts the representation of the
local cerebral features when creating smoothed volumes. To make
this mask, we used the extracerebral voxel removal mask described
in the Image Preprocessing Section and excluded voxels in the mask
that appear hypointense in the FLAIR volume. Because CSF is
hypointense in the FLAIR, we empirically found that excluding voxels
falling below the bottom 15th percentile of FLAIR intensities over the
extracerebral voxel removal mask removes CSF outside of the brain
and in the ventricles. We refer to this mask as the brain tissue mask.
Fig. 2B1 shows a slice of the brain tissue mask for a particular subject
for illustration.
2.6. Intensity normalization
We used intensities from the FLAIR, PD, T2-weighted, and T1-
weighted volumes to identify the presence of MS lesions. We denote
the observed intensity of voxel v, for subject i by:
M0i vð Þ;M ¼ FLAIR; PD; T2; T1
where M indicates the imaging sequence.
MRI volumes are acquired in arbitrary units. Analyzing images
across subjects and imaging centers requires that images be normal-
ized so that voxel intensities have common interpretations. For nor-
malization, we adapt the normalization method from Shinohara et
al. (2011) to normalization with respect to the brain tissue mask.
The normalized intensity of voxel v, for subject i is denoted by:
MNi vð Þ ¼
M0i vð Þ−μ0i;M
σ0i;M
where μi,M0 and σi,M0 are the mean and standard deviation of the ob-
served voxel intensities in the brain tissue mask of subject i, from se-
quenceM. The normalized voxel intensities are standard scores of the
brain tissue mask. Fig. 1A shows a slice of the normalized images from
all four modalities from a single subject with MS: FLAIR, T2-weighted,
PD, and T1-weighted.
2.7. Smoothed volumes
To account for intensity inhomogeneities that remain after initial
inhomogeneity correction, we use a sequence of multiresolution
smoothed volumes, obtained using different levels of smoothing.
The smoothed volumes are created by three dimensional smoothing
of the normalized volume from each modality over the brain tissue
mask. A Gaussian smoother with relatively large kernel window size
is used to smooth over the features in the brain and capture the pat-
tern of the remaining inhomogeneity.
For subject i and imaging modalityM, let k be the size of the kernel
window. Then the intensity in voxel v of the smoothed volume of
Fig. 1. A. Axial slice from different modalities of intensity normalized brain MRI of a single subject: A1. FLAIR image. A2. T2-weighted image. A3. PD image. A4. T1-weighted image. B. Brain
tissue mask of an axial slice of the brain. C. Axial slice of select voxels for OASIS modeling. D. Manual lesion segmentation of an axial slice of the brain. E. Axial slice of brain tissue
mask with dilated lesion mask made at a false positive rate of 1% removed. F. Axial slice of the smoothed probability map with intensity scale. G. Binary segmentation of the
probability map from the OASIS model at false positive rate of .005 overlaid on the FLAIR image.
405E.M. Sweeney et al. / NeuroImage: Clinical 2 (2013) 402–413imaging modalityM is expressed asGMNi v; kð Þ. The smoothed volumes
are used in the OASIS model to incorporate spatial information and to
account for inhomogeneities in the brain that persist after N3 correc-
tion. For OASIS we use smoothed volumes as covariates with kernel
window sizes of 10 and 20 voxels, which were found empirically on
Validation Set 1 to work well. Fig. 2 shows the smoothed volumes
for both kernel window sizes of 10 and 20 from each modality. The
kernel window size of 20 smooths over the anatomical features al-
most completely, while the kernel window size of 10 still preserves
some of these features, such as the hyperintensities of the gray matter
in the FLAIR, T2-weighted, and PD volumes and hypointensities of the
gray matter in the T1-weighted volume.
2.8. OASIS is Automated Statistical Inference for Segmentation
In this section we introduce the OASIS model. OASIS uses logistic
regression to model the probability that a voxel is part of a lesion.
We choose logistic regression because it is extremely simple andeasy to interpret. We model lesions at the voxel level using FLAIR,
PD, T2-weighted, and T1-weighted intensities as well as the intensi-
ties from the smoothed volumes of each modality with kernel win-
dow sizes of 10 and 20 voxels. The model must be trained on a gold
standard measure of lesion presence. Fig. 1D is an example of manual
lesion segmentation, which is an appropriate gold standard measure
for the OASIS model. The result of our model is a collection of coefﬁ-
cients that can be used to create three-dimensional maps of the prob-
abilities of lesion presence. OASIS obtains the estimated logit of the
probability of each voxel being part of a lesion by weighting these
12 images (the four imaging modalities and smoothed volumes for
each modality) with the coefﬁcients.
The ﬁrst step of themodeling procedure is to select candidate voxels
to minimize false positives and computation time. Lesions appear as
hyperintensities in the FLAIR volume. The brain tissuemaskwas applied
to the FLAIR volume, and the 85th percentile and above of voxels in the
brain tissuemaskwere selected as candidate voxels for lesion presence.
In Validation Set 1, there were a total of 1,093,394 lesion voxels (a
FLAIR T2-weighted T1-weighted
20
10
PD
Fig. 2. Axial slice from a single subject of the smoothed volumes from all modalities. Row one contains the smoothed volumes with kernel window size of 10 and row two contains
the smoothed volumes with kernel window size of 20. Column A contains the FLAIR images, B contains the T2-weighted images, C contains the PD images and D contains the
T1-weighted images. To link the ﬁgure with the notation used in this paper: A1. GFLAIRNi v; 10ð Þ; A2. GFLAIRNi v;20ð Þ; B1. GT2Ni v;10ð Þ; B2. GT2Ni v;20ð Þ; C1. GPDNi v;10ð Þ; C2.
GPDNi v; 20ð Þ; D1. GT1Ni v;10ð Þ; D2. GT1Ni v;20ð Þ; and E. Scale of intensities in the smoothed volumes.
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(6%) of these voxels, but lowered the searchable area to 15% of the orig-
inal size. This procedure also decreases the number of potential false
positive voxels. Using this threshold also signiﬁcantly decreases the
number of voxels the model must be ﬁt on, allowing for a much faster
ﬁt. Fig. 1C shows a slice of the voxel selection mask for a single subject.
We then ﬁt a voxel-level logistic regression model over the candi-
date voxels. In the OASIS model, the probability that a voxel is part of
a lesion is represented as P{Li(v) = 1}, where L is a random variable
denoting voxel-level lesion presence. If there is a lesion in voxel v
for subject i, then Li(v) = 1. Otherwise, Li(v) = 0. The probability
that a voxel v contains lesion incidence is modeled with the following
logistic regression model:
logit P Li vð Þ ¼ 1f g½  ¼ β0 þ
β1FLAIR
N
i vð Þ þ β2GFLAIRNi v;10ð Þ þ β3GFLAIRNi v;20ð Þ þ
β4PD
N
i vð Þ þ β5GPDNi v;10ð Þ þ β6GPDNi v;20ð Þ þ
β7T2
N
i vð Þ þ β8GT2Ni v;10ð Þ þ β9GT2Ni v;20ð Þ þ
β10T1
N
i vð Þ þ β11GT1Ni v;10ð Þ þ β12GT1Ni v;20ð Þ 1½ 
þ β13FLAIRNi vð Þ  GFLAIRNi v;10ð Þ þ β14FLAIRNi vð Þ  GFLAIRNi v;20ð Þ
þ β15PDNi vð Þ  GPDNi v;10ð Þ þ β16PDNi vð Þ  GPDNi v;20ð Þ
þ β17T2Ni vð Þ  GT2Ni v;10ð Þ þ β18T2Ni vð Þ  GT2Ni v;20ð Þ
þ β19T1Ni vð Þ  GT1Ni v;10ð Þ þ β20T1Ni vð Þ  GT1Ni v;20ð Þ
:
The effect of magnetic ﬁeld inhomogeneities is thought to be multi-
plicative, so we use the interactions between the normalized volume
and the smoothed volume in the model.
2.9. OASIS model reﬁnement
The second iteration of the OASIS model ﬁtting is done to reduce
the inﬂuence of lesions in the smoothed volumes. First, we ﬁt the
model and use the estimated coefﬁcients to create maps of the esti-
mated probability of lesion presence at each voxel. To incorporate
spatial information of the neighboring voxels and reduce noise, we
smooth the estimated probabilities from the model using a Gaussian
kernel with window size of 3 mm. This kernel size was empirically
chosen and found to perform well. The resulting probability maps
were then thresholded using a liberal false positive rate of 1% (thresh-
old value of 0.10), which resulted in model based hard segmentations
of lesions. These lesion masks were then dilated by 5 voxels to ensurethat the entire lesion was captured and removed from the brain tissue
mask. Fig. 1E shows the brain tissue mask with the lesions removed.
New smoothed volumes were created by applying a Gaussian
smoother with kernel window sizes of 10 and 20 to the normalized
image from each modality over the brain tissue mask with the lesions
removed. We inpainted the smoothed volumes to ﬁll the places
where lesions were removed with the values we would expect in
this area if it were occupied by normal, healthy tissue.
The intensity in voxel v of the normalized image after the second
Gaussian smoother has been applied is labeled as, G2MNi v; kð Þ. Fig. 3
shows an axial slice for a subject of the FLAIR volume and the
smoothed volume for this image with kernel window sizes of 10
and 20 before and after the lesions were removed. To link the ﬁgure
with the notation, Fig. 3A shows FLAIRiN(v), Fig. 3B shows a scale of in-
tensities in the smoothed volumes, Fig. 3C1 shows GFLAIRNi v;10ð Þ,
Fig. 3C2 shows G2FLAIRNi v;10ð Þ, Fig. 3D1 shows GFLAIRNi v;20ð Þ, and
Fig. 3D2 shows G2FLAIRNi v;20ð Þ. The lesions are captured in the ﬁrst
smoothed volume, especially with the kernel size of 10, but are not
captured in the second smoothed volume. The model [1] was reﬁt
over the same voxels using the second smoothed volume to obtain
the ﬁnal coefﬁcients that are used to create the ﬁnal probability
maps. Again, the ﬁnal estimated probabilities are smoothed using a
Gaussian kernel with window size of 3 mm. Fig. 1F shows a slice of
the probability map for a subject and a scale of intensities. Red indi-
cates areas with a higher probability of being a lesion and blue indi-
cates areas with a lower probability of being a lesion.
2.10. Probability map and binary segmentation
Using this ﬁtted model to generate a probability map for the entire
brain from a set of new images takes about 30 min for each study
using a standard workstation. The Gaussian smoothing is the slowest
step of the algorithm and takes approximately one minute for each
volume. These computations can be parallelized to take substantially
less time; the entire algorithm can be run in approximately 5 min
with 8 cores. To make a probability map for a new study, the two
sets of regression coefﬁcients, a brain mask, and the FLAIR, PD,
T2-weighted, and T1-weighted volumes are required. Using population-
level thresholds, the probability maps from OASIS can be used to create
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Fig. 3. Axial slice of the FLAIR volume and the ﬁrst and second smoothed volumes created from the FLAIR image for a single subject. To link the ﬁgure with the notation used in this
paper: A. FLAIRiN(v) B. Scale of intensities in the smoothed volumes C1. GFLAIRNi v;10ð Þ; C2. G2FLAIRNi v; 10ð Þ; D1. GFLAIRNi v; 20ð Þ; and D2. G2FLAIRNi v;20ð Þ.
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mentation overlaid on the FLAIR image. A summary of how to apply the
OASIS method to a newMRI study can be found in the Appendix.2.11. Validation with gold standard: Validation Set 1
Validation Set 1, described in detail in the Materials and methods
section, consists of 131 MRI studies: 98 studies from MS subjects and
33 studies from healthy subjects. To ﬁt the model and to measure per-
formance, we required a set of data in which the outcome is assessed
using a gold standard measure. The gold standard was obtained using
manual segmentation by a technologist with more than 10 years of
experience in delineating white matter lesions. The technologist
spent between 30 min to an hour segmenting each study, depending
on the lesion load and distribution. The majority of the studies
had at least moderate pathology and therefore took between
45 min to an hour. The segmentations were made from the FLAIR
and T1-weighted volumes. Fig. 1D shows a manually segmented
slice for a subject. The mean volume of lesions for MS subjects in Val-
idation Set 1 is 11.2 cm3 (IQR: [1.7 cm3, 16.6 cm3]). It was assumed
that the healthy subjects did not have any lesions.
To evaluate the performance of our model within Validation Set 1,
we trained the model [1] on 20 randomly selected subjects (15 MS
subjects and 5 healthy subjects) and tested on the remaining 111 sub-
jects (83 MS subjects and 28 healthy subjects). We used only the
studies from the 111 subjects in this test set to estimate the
voxel-level receiver operating characteristic (ROC) curve and area
under the curve (AUC). These performance measures are known to
be susceptible to instability. To account for this, we nonparametrically
bootstrapped with replacement the subjects to the training andtesting sets. We then ﬁt the model on the training set and observed
the performance of the model in the testing set.
It is known that the full AUC summarizes test performance over
regions of the ROC space that are not clinically relevant for lesion seg-
mentation (Sweeney et al., 2013). Once a test has been able to distin-
guish well between disease and not disease, the performance of the
test for particular applications must be evaluated, in which case one
may be interested in only a small portion of the ROC curve
(Obuchowski, 2003). In this particular application we are interested
in using the lesion segmentation to identify lesions and to provide ac-
curate estimations of lesion volumes. The mean lesion volume of
manual lesion segmentations from Validation Set 1 is 11.2 cm3 (IQR
[1.7 cm3, 16.6 cm3]). For the entire brain, a false positive rate of .01
would correspond to a volume of 12.8 cm3 of healthy brain being
falsely identiﬁed as lesion, which is more than the mean lesion vol-
ume in Validation Set 1. Therefore we examined only false positive
rates below 1%. We provide the partial ROC curve with bootstrapped
95% conﬁdence bands for clinically relevant false positive rates of 1%
and below.
2.12. Validationwith expert rankings: Validation Set 1 and Validation Set 2
For the studies in Validation Set 2, gold standard segmentations
were not available. To evaluate the performance of OASIS on Validation
Set 2, three experts (a neuroradiologist, neurologist, and radiologist)
compared OASIS segmentations to those from LesionTOADS, an open-
source lesion segmentation software (http://www.nitrc.org/projects/
toads-cruise/), (Shiee et al., 2008a,b, 2010). Validation Set 2, described
in detail in theMaterials andmethods section, consists of 169MRI stud-
ies of 149 subjects, 20 of whomhad follow-up visits. These studieswere
acquired using a variety of imaging protocols.
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Fig. 4. Partial ROC curve for the voxel-level detection of lesions in the testing set of
Validation Set 1 for different thresholds of the probability maps produced from
OASIS for clinically relevant false positive rates of 1% and below. Bootstrapped 95% con-
ﬁdence bands are also provided. The vertical axis of the partial ROC curve shows the
true positive rate (sensitivity) for a given threshold of the probability map and the hor-
izontal axis shows the false positive rate (1 — speciﬁcity) for this threshold.
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when moving to a new dataset is the population-level threshold.
For Validation Set 2 we used the coefﬁcients that were trained on Val-
idation Set 1 and then empirically adjusted the population level
threshold for Validation Set 2. To adjust this threshold, we randomly
sampled 10 subjects from Validation Set 2. We applied thresholds be-
tween 0.10 and 0.50 (by increments of 0.05) to the probability maps,
examined the segmentation, and empirically chose a threshold of
0.35 for Validation Set 2. This threshold adjustment is very fast and
transparent. We ran the segmentations for the 10 subjects in parallel,
and each segmentation took less than 5 min. Next, we thresholded
the probability maps at the 9 different thresholds, which took only
seconds. Last, we looked through the segmentations and the original
images to select the optimal (most reasonable) threshold, which took
only about a minute for each subject. The entire process of tuning the
threshold took less than an hour and involved only 10 min of manual
image examination. This procedure only needs to be performed once
when moving to a new imaging center or study. For the segmentation
comparison, we presented the three experts with segmentations at
the threshold value of 0.35 on all of the images in Validation Set 2
as well as at the threshold from Validation Set 1 with a false positive
rate of 0.005, a threshold value of 0.16. We will refer to the threshold
value of 0.35 as the empirically adjusted threshold and the threshold
value of 0.16 as the Validation Set 1 threshold.
We compared both OASIS segmentations to the segmentations
produced by the open source software LesionTOADS. We ran
LesionTOADS with T1-weighted and FLAIR inputs and the default pa-
rameters. We adjusted the smoothing parameter from 0.2 to 0.4 be-
cause we empirically found this to improve the quality of the
segmentations. It is important to note that LesionTOADS not only seg-
ments lesions, but also segments the other tissue classes of the brain.
For this analysis, we only used the lesion segmentations.
We designed an image rating system to evaluate the performance
of the two segmentation algorithms. For each of the 169 studies, we
had three segmentations: the LesionTOADS segmentation, the OASIS
segmentation with the threshold from Validation Set 1, and the
OASIS segmentation with the empirically adjusted threshold. We
also randomly selected 20 of the MRI studies and created duplicates
of these to assess rating reliability, for a total of 189 studies. We ran-
domized the order in which the segmentations were presented to the
experts and randomly assigned each segmentation a letter: A, B, or C,
so as to blind the rater to the segmentation algorithm.
Wepresented each of the 189MRI studies to an experiencedMSneu-
roradiologist. For each study, the neuroradiologist examined the set of
three segmentations along with the original FLAIR, PD, T1-weighted,
and T2-weighted volumes. The neuroradiologist then scored the perfor-
mance of each of the segmentations on a continuous scale from 0 to 100,
with 0 being an unusable lesion segmentation and 100 being a perfect
segmentation. The neuroradiologist was presented all three segmenta-
tions simultaneously, so that scoreswere assigned relative to one anoth-
er. Fifty of the studies were selected to be scored with the same system
by a neurologist with a subspecialty in MS and a general radiologist in
order to assess rater agreement among the three raters. The 50 studies
were comprised of 45 randomly selected studieswith 5 of the studies re-
peated to assess rater reliability.
The neuroradiologist also compared and scored the OASIS and
LesionTOADS segmentations from the studies for the 98 MS patients
in Validation Set 1. This allows for comparison of the performance
of the segmentations on Validation Set 1 and Validation Set 2.
3. Experimental results
3.1. Validation Set 1: training with gold standard
The OASIS model has an estimated full AUC of 98% (95% CI; [96%,
99%]) and a partial AUC for clinically relevant false positive rates of1% and below of 0.59% (95% CI; [0.50%, 0.67%]) in the test set. Fig. 4
shows the voxel-level partial ROC curve for the test set with
bootstrapped 95% conﬁdence bands for clinically relevant false posi-
tive rates. The probability map threshold that corresponds to a false
positive rate of 1% is 0.10. The vertical axis of the partial ROC curve
shows the true positive rate (sensitivity) for thresholds between 0
and 0.10 of the probability map and the horizontal axis shows the
false positive rate (1 — speciﬁcity) for these thresholds.
The coefﬁcients from ﬁtting the logistic model [1] over all 131
studies in Validation Set 1, a total of 24 million voxels, are reported
in the Appendix. The coefﬁcients from the ﬁrst and second ﬁt of the
model are provided. We also assessed the variation in the coefﬁcients
by nonparametrically bootstrapping the subjects with replacement.
The bootstrapped 95% conﬁdence intervals for the coefﬁcients can
be found in the Appendix. The variance of these coefﬁcients is large
in comparison to the estimates of the coefﬁcients. The instability in
the coefﬁcients does not impact the performance of OASIS, as illus-
trated in the stability of the partial ROC curve.
Choosing a ﬁnal threshold value after the second probability maps
are made is a tradeoff between sensitivity and speciﬁcity. OASIS is
ﬂexible, and the appropriate false positive rate may be selected for a
particular application. Table 2 shows the threshold values, sensitivity,
and dice similarity coefﬁcient (Dice, 1945) for four different false pos-
itive rates for the model ﬁt over all of the studies in Validation Set 1.
OASIS detected lesions in many of the healthy subjects. Table 3 shows
the mean volume of false positive lesions detected in the healthy and
MS subjects for the four threshold values from Table 2. The volume of
false positives for both the MS and healthy subjects is comparable.
3.2. Validation Set 1: neuroradiologist rating results
For the neuroradiologist rankings of the OASIS and LesionTOADS
segmentations for the 98 MS subjects in Validation Set 1, we
performed a paired t-test to assess the difference in the means of
the OASIS segmentations and the LesionTOADS scores. This difference
was found to be 12.6, with a 95% conﬁdence interval of (9.6, 15.8),
p-value b 10−12. The OASIS empirical threshold was ranked higher
Table 2
Binary segmentation thresholds with false positive rate, sensitivity and DSC for Valida-
tion Set 1.
False positive rate Sensitivity Threshold value DSC
1% 80% 0.10 0.55
0.75% 76% 0.12 0.58
0.5% 69% 0.16 0.61
0.25% 58% 0.23 0.59
Table 4
Summary statistics of image ratings of Validation Set 2 for neuroradiologist on 189
studies.
OASIS OASIS LesionTOADS
Validation Set 1 threshold Empirical threshold
Minimum 3.7 3.7 2.7
1st quantile 27.3 55.7 21.7
Median 42.0 68.3 51.0
Mean 43.2 64.1 47.5
3rd quantile 57.7 76.3 71.0
Maximum 99.3 99.0 97.3
409E.M. Sweeney et al. / NeuroImage: Clinical 2 (2013) 402–413than LesionTOADS segmentation in 73 (95% CI: [64, 81]) of the 98 stud-
ies or 74%(95% CI: [65%, 82%]). We nonparametrically bootstrapped
with replacement the subjects to produce the conﬁdence intervals for
the rankings.
3.3. Validation Set 2: neuroradiologist rating results
Table 4 contains summary statistics for the scores from the neuro-
radiologist ratings of the three segmentations for all 189 studies. The
OASIS Validation Set 1 threshold segmentations and the LesionTOADS
segmentations have a much lower ﬁrst quantile than the OASIS em-
pirical threshold segmentations. For this analysis we focus mainly
on the difference between the OASIS empirical threshold and the
LesionTOADS segmentation, as the OASIS Validation Set 1 threshold
did not perform well on this new data set. This was expected, as the
probability map threshold needs to be adjusted to maintain the same
false positive rate when moving to a new data set. We performed a
paired t-test to assess the difference in themeans of the OASIS empirical
threshold scores and the LesionTOADS scores. This difference was
found to be 16.6, with a 95% conﬁdence interval of (13.3, 20.0),
p-value b 10−14. The OASIS empirical threshold was ranked higher
than LesionTOADS segmentation in 146 (95% CI:[135, 157]) of the 189
cases or 77% (95% CI: [71%, 83%]). We nonparametrically bootstrapped
with replacement the subjects to produce the conﬁdence intervals for
the rankings.
To assess rater reliability among the 20 duplicated MRI studies, we
calculated the intraclass correlation coefﬁcient: 0.61 (95% CI: [0.69,
0.81]). The rankings for the LesionTOADS images and the OASIS em-
pirical threshold were preserved in the duplicate rankings for 17 of
the 20 images (95% CI: [14, 20]). We nonparametrically bootstrapped
with replacement the subjects to produce the conﬁdence intervals for
both the intraclass correlation coefﬁcients and the rankings.
3.4. Validation Set 2: rater agreement with neuroradiologist, neurologist,
and radiologist
Table 5 contains summary statistics for the scores from the neurora-
diologist, neurologist, and radiologist ratings of the three segmentations
for the set of 50 studies selected to asses rater reliability. Fig. 5 shows a
notched box plot for each rater of these ﬁndings. From the box plot we
see that there is a statistically signiﬁcant difference between the me-
dians for all three segmentations for the neuroradiologist and neurolo-
gist. There was not a statistically signiﬁcant difference in themedians of
the scores for the three segmentations by the radiologist. Moreover, all
three raters indicated that the OASIS Validation Set 1 segmentationsTable 3
Volume of false positive lesion in healthy volunteers and MS subjects from Validation
Set 1 (in cm3); the actual mean lesion volume is 0 cm3 for healthy volunteers and
11.2 cm3 (IQR: [1.7 cm3, 16.6 cm3]) for MS subjects.
Threshold value Healthy mean (IQR) MS mean (IQR)
0.10 8.6 (4.6, 10.6) 10.9 (7.6, 13.6)
0.12 6.7 (3.1, 8.2) 8.0 (5.2, 10.3)
0.16 4.3 (1.5, 5.7) 5.2 (3.0, 7.0)
0.23 2.2 (.7, 2.8) 2.5 (1.2, 3.5)and the LesionTOADS segmentations have a much lower ﬁrst quantile
than the OASIS empirical threshold segmentations. The outliers in the
boxplots can be explained as either errors in processing, such as regis-
tration or bad artifacts, or as studies that none of the segmentation
methods performed well on. We did not remove these studies from
the analysis, because we want to assess the performance of OASIS in
the setting of an image processing pipeline, where images may not be
properly registered or may contain artifacts.
Again, we will focus mainly on the difference between the OASIS
empirical threshold and the LesionTOADS segmentation.We performed
a paired t-test to assess the difference in the means of the OASIS empir-
ical threshold scores and the LesionTOADS scores. These differences can
be found in Table 5. The mean for the OASIS empirical threshold was
greater than the mean for the LesionTOADS scores for all three raters.
This difference was found to be statistically signiﬁcant for both the
neuroradiologist and neurologist, (p-values b 10−4 and b 10−3, respec-
tively), but not for the radiologist, (p-value 0.5). The neuroradiologist
and the neurologist tended to spread their scores more, and this
allowed better comparison of the segmentation algorithms. Table 5
also shows the percentage of time the OASIS empirical threshold was
ranked higher than LesionTOADS segmentation in the 50 studies. We
nonparametrically bootstrapped with replacement the subjects to pro-
duce the conﬁdence intervals for the rankings.
To assess rater reliability among the 5 duplicated MRI studies, we
calculated the intraclass correlation coefﬁcient and the number of
times the rankings for the LesionTOADS images and the OASIS empir-
ical threshold were preserved. We nonparametrically bootstrapped
with replacement the subjects to produce the conﬁdence intervals
for both the intraclass correlation coefﬁcients and the rankings. For
the neuroradiologist, the intraclass correlation coefﬁcient for the 5 re-
peated studies is 0.55 (0.21, 0.82) and the number of preserved rank-
ings is 4 (2,5). For the neurologist, 0.32 (−0.10, 0.68) and 4 (2,5). For
the radiologist, −0.38 (−0.35, 0.71) and 2 (0,4). The repeated rank-
ings for each rater for the 5 subjects are reported in the Appendix.
We calculated the rater agreement for the ranking of the OASIS
empirical threshold versus LesionTOADS. We decided to use the rank-
ings of the scores to assess rater agreement rather than the scores
themselves, because, as shown from the intraclass correlation coefﬁ-
cient, the scores are not very reliable, while the order in which the ob-
servers rank the segmentations, on the other hand, is quite reliable.
We calculated the kappa statistic to assess the reliability of the rank-
ings for each pair of raters and nonparametrically bootstrapped with
replacement the subjects to produce the conﬁdence intervals for the
kappa statistics. The kappa statistic for the rater agreement between
the neuroradiologist and the neurologist was 0.47 (0.20, 0.75), the
neuroradiologist and radiologist 0.02 (−0.26, 0.30) and the neurolo-
gist and radiologist −0.09 (−0.37, 0.19).
4. Discussion
OASIS may be used to assist or even replace manual segmentation
of MS lesions in the brain. After training and adjustment of the popu-
lation level threshold, our fully automatic method does not require
Table 5
Mean and standard deviation of the rating from the neuroradiologist, neurologist, and radiologist for OASIS Validation Set 1 threshold, OASIS empirical threshold and LesionTOADS
on 50 studies from Validation Set 2; mean difference between OASIS empirical threshold and LesionTOADS and percentage of times OASIS was ranked higher than LesionTOADS on
these images.
OASIS OASIS LesionTOADS Mean Percentage
Validation Set 1 Empirical Mean (SD) Difference Rank
Mean (SD) Mean (SD) (95% CI) (95% CI)
Neuroradiologist 46.3 (22.0) 66.1 (20.2) 47.3 (27.2) 18.7 (11.2, 26.3) 76% (64%, 88%)
Neurologist 48.7 (24.3) 73.1 (18.5) 56.6 (26.0) 16.5 (7.0, 25.9) 66% (52%, 78%)
Radiologist 71.6 (19.6) 74.1 (17.9) 71.8 (16.5) 2.3 (−4.2, 8.8) 52% (38%, 66%)
410 E.M. Sweeney et al. / NeuroImage: Clinical 2 (2013) 402–413human input and avoids the variability introduced by manual seg-
mentation. Using the explicit form of the statistical model, OASIS
can easily be adapted and trained for cases where more or fewer im-
aging sequences are available.
With the OASIS model, a recalibration of the population-level seg-
mentation threshold is necessary for each new data set but can be
done on a fairly limited number of subjects, as in the example from
this paper. A recalibration of the population-level segmentation
threshold is necessary for each new data set but can be done on a fair-
ly limited number of subjects, as in the example from this paper. A set
of subjects is required to tune this population level threshold, there-
fore fully automatic segmentation of a single study from a new imag-
ing center may not be feasible with the OASIS model. However, in
these cases the threshold can be adjusted very quickly manually
(2–5 min) by visual inspection of 3–4 slices by adjusting just one pa-
rameter. When using an ROC curve for classiﬁcation, thresholds for
subpopulations with different covariate values may need to be de-
ﬁned differently in order to keep false positive rates the same across
those subpopulations (Pepe, 2003). Therefore, it was expected that
the ROC threshold would need to be adjusted to maintain the same
false positive rate from Validation Set 1 in Validation Set 2. This
threshold is the only tuning parameter in OASIS that must be adjusted
when moving to a new data set, and this adjustment is very fast and
intuitive to make and does not require multiple iterations of segmen-
tations. We believe that OASIS holds promise for use in multicenter
MRI studies, with adjustment of the population level threshold for
each site.
Future work includes further validation of OASIS under changes in
imaging center and protocol and to also show the reproducibility of
the OASIS segmentations. One resource for this is the MS Lesion Seg-
mentation Challenge (Styner et al., 2008), a common database for MS
lesion segmentation algorithms. We plan to do further validation
with this database as well as with volumes from additional imaging
centers. For this analysis we did not have scan-rescan MRI available.0
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Fig. 5. Notched box plot of the results from the neuroradiologist, neurologist, and radiologist
Validation Set 1 threshold segmentations, the OASIS empirically adjusted threshold segmenThese are crucial for assessing the reproducibility of the method,
and we plan to acquire these in the future.
In contrast to many automatic segmentation techniques, OASIS is
computationally fast. While training the model on the 131 studies
from Validation Set 1 takes ﬁve hours on a standard workstation,
this process is only conducted once. The results from this are summa-
rized as the two sets of 21 coefﬁcients in model [1]. Also, the model
may be trained on fewer studies, as shown in the partial ROC analysis
within Validation Set 1; the performance of the model remains stable
when trained on subsets of 20 studies. Using this ﬁtted model to gen-
erate a probability map of the entire brain from a set of new images
takes only 30 min. These times are for standard workstations and
are expected to drop dramatically with multi-core parallel computing
and improved technologies. The Gaussian smoothing is the slowest
step of the algorithm, and these computations can be parallelized to
substantially decrease the time of the entire algorithm to approxi-
mately 5 min.
Aftermaking the image ratings for Validation Set 2, the neuroradiol-
ogist was unblinded and reviewed the three segmentations, providing
comments about the strengths and weaknesses of each. The OASIS em-
pirical threshold performedmuchbetter than theOASIS Validation Set 1
threshold. The neuroradiologist reported a preference for the smooth-
ness of the OASIS segmentations in contrast to the LesionTOADS seg-
mentation, which often appeared speckled. The OASIS segmentations
often had artifacts in the pineal glands and the choroid plexus of the
ventricles. This may be explained by the fact that OASIS was trained
on FLAIR images acquired before a gadolinium-based contrast agent
was administered to the patient, while the validation was done with
FLAIR images that were acquired after gadolinium administration.
Voxels in the choroid plexus and pineal glands, which enhance with
gadolinium, were brighter and were thus misclassiﬁed as lesion.
LesionTOADS does not make a similar error, as it imposes topological
constraints that preclude these structures from being identiﬁed as le-
sions. Further reﬁnements of OASIS may account for such complexage Ratings Radiologist Image Rantings
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image ratings for segmentations of the 50 MRI studies from Validation Set 2: the OASIS
tations, and the LesionTOADS segmentations.
411E.M. Sweeney et al. / NeuroImage: Clinical 2 (2013) 402–413changes of protocol. The LesionTOADS segmentations were more vari-
able than those of OASIS and did not performwell on cases with low le-
sion load. The OASIS segmentation had systematic errors in the medial
frontal cortex and the brainstem. On the other hand, LesionTOADS
avoided false positives in the brainstem because it only segments le-
sions in the cerebrum. Fig. 6 shows a slice from a subject with an exam-
ple of a lesion that OASIS segments in the cerebellum. Fig. 6A shows a
single slice of the FLAIR volume, Fig. 6B shows a single slice of the
T1-weighted volume, Fig. 6C shows the LesionTOADS segmentation of
the slice, and Fig. 6D shows the OASIS segmentation of the slice.
LesionTOADS does not segment the cerebellum, whereas OASIS does
not restrict the areas that it segments and is able to ﬁnd the lesion in
this slice.
OASIS is not an atlas-based method and therefore does not take
into account anatomical information during segmentation, such as
tissue class. Further incorporation of anatomical information, such
as the tissue class segmentations from LesionTOADS, may help to
avoid lesions false positives in areas where we have prior knowledge
that lesion presence is low and where OASIS made systematic false
positives, such as the medial frontal cortex and the brainstem. Also,
this could be used to help with the false positives in the pineal glandsA
C
Fig. 6. Example of a cerebellum lesion classiﬁed using OASIS in Validation Set 2: A. FLAIR vo
adjusted threshold segmentation.and the choroid plexus of the ventricles in the post-contrast FLAIR as
these are areas where lesions do not occur in MS.
The smoothed images used in OASIS are similar to the use of
smoothed images for inhomogeneity correction in MRI. For inhomoge-
neity correction, an image is smoothed to suppress the details of the
image and then the original image is divided by this smoothed image
in order to correct the image inhomogeneity (Axel et al., 1987). Our
method differs from this in that we do not divide the original image
by the smoothed volume. Insteadwe use the smoothed volume as a co-
variate in ourmodel.We also usemultiresolution smoothed volumes, in
contrast to just one smoothed volume for correction.
Other methods of capturing inhomogeneities may be used in the
OASIS model as an alternative to the smoothed volumes. Alternative
smoothers may be used instead of the Gaussian kernel and may be
more appropriate in other applications. We decided to use the Gauss-
ian ﬁlter because it is widely used, can be applied to any image, and is
relatively computationally fast. The OASIS modeling framework is
very ﬂexible, however, and can be adapted for other methods of cap-
turing the bias ﬁeld and regional intensity variation.
We used the 15th percentile of FLAIR intensities in the brain to
create the brain tissue mask. Other segmentations can be used toB
D
lume; B. T1-weighted volume; C. LesionTOADS segmentation; and D. OASIS empirically
412 E.M. Sweeney et al. / NeuroImage: Clinical 2 (2013) 402–413remove the CSF. We used the 15th percentile of FLAIR intensities be-
cause it is fast and performed well in this application.
Lesions that are hypointense on FLAIR, because of high free water
content, are not detected by OASIS. The method models only candidate
voxels, the top 15% of voxels in the cerebral matter-masked FLAIR vol-
ume, to minimize the number of false positives. In the FLAIR volume,
such lesions are characterized by hypointensities in the center of a le-
sion and hyperintensities around the edges. Therefore the center of
the lesions is excluded from the candidate voxels. Future work includes
expanding the OASIS model to segment these lesions. This could be
done by ﬁtting another OASIS model trained only on lesion voxels
that appear hypointense in FLAIR lesions. The binary segmentations
from the original OASIS model and this model could then be combined
to produce a complete lesion segmentation.
Like other voxel-based methods, OASIS is sensitive to major mis-
registrations within an MRI study. However, in part because it incor-
porates spatial smoothing, OASIS is not sensitive to minor errors in
registration. By simultaneously comparing data from multiple se-
quences and only considering candidate voxels, OASIS is able to dis-
tinguish between artifacts and lesion.
OASIS uses a voxel-level model for assessing the outcome. The as-
sumption of independence between voxels is imperfect, as lesions
consist of clusters of voxels. In this work we use smoothing in the
smoothed volumes and smoothing of the predicted probabilities of
the model to incorporate the spatial nature of the data. Nevertheless,
further incorporation of neighboring voxel information is warranted.
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